a concise, efficient, and scalable total synthesis of ...ccc.chem.pitt.edu/wipf/current...
TRANSCRIPT
A Concise, Efficient, and Scalable Total Synthesis ofThapsigargin and Nortrilobolide from (R)-(-)-Carvone
Dezhi Chen and P. Andrew EvansJ. Am. Chem. Soc. 2017, 139, 6046.
Evan CarderWipf Group Current Literature
June 24, 2017 06/24/17 1
H
OMe
HO
O
O
OHMe
Me O
O
Me
OPr
OO
OMe
6OMe
Me
Thapsigargin
Me
HH
O
(R)-(-)-Carvone
Evan Carder @ Wipf Group Page 1 of 24 8/7/2017
Origins of Thapsigargin
02/11/17 EvanCarder@WipfGroup 2
1. Acta Pharm. Suec. 1978, 15, 133.2. J. Org. Chem. 1982, 47, 649.3. Tetrahedron Lett. 1985, 26, 107.
§ Associated in folk medicine
§ Isolated from the roots of Thapsiagarganica L. in 1978 by Christensen and coworkers.1
§ Chemical structure was elucidated by extensive spectroscopic studies and X-ray crystallography.2,3
§ A member of 17 structurally-related sesquiterpenones, which are collectively known as thapsigargins.
Evan Carder @ Wipf Group Page 2 of 24 8/7/2017
Structural Features of Thapsigargin
02/11/17 EvanCarder@WipfGroup 3
§ 5-7-5 tricyclic core
§ Eight stereogenic centers
§ Polyoxygenated
§ Functionalized with four different ester groups
§ Thapsgargins primarily differ in the acyl groups appended to O-2 or O-8.1
§ Three distinct syntheses have been reported: Steven Ley2, Phil Baran3, and P. Andrew Evans4
H
OMe
HO
O
O
OHMe
Me O
O
Me
OPr
OO
OMe
6OMe
Me
23
6 7
8
110
11
Thapsigargin
1. Chem. Eur. J. 2007, 13, 5688.2. Angew. Chem., Int. Ed. 2003, 42, 5996.3. ACS Cent. Sci. 2017, 3, 47.4. J. Am. Chem. Soc. 2017, 139, 6046.
Evan Carder @ Wipf Group Page 3 of 24 8/7/2017
Biological Relevance of Thapsigargin
02/11/17 EvanCarder@WipfGroup 4
§ Extensive biological evaluation
§ Selective, sub-nanomolar inhibitor of sarco/endoplasmic reticulum calcium ATPase (SERCA)-dependent pumps.1,2
§ Binds to SERCA and induces a conformation that deters calcium and ATP binding.1,2
§ Treatment severely alters cellular calcium concentrations, leading to disrupted cell growth and programmed cell death.3,4
§ Promising therapeutic potential 1. J. Biol. Chem. 1991, 266, 13503.2. J. Biol. Chem. 1995, 270, 11731.3. J. Biol. Chem. 1994, 269, 11927.4. Prostate 1997, 80, 201.
Evan Carder @ Wipf Group Page 4 of 24 8/7/2017
Total Synthesis by the Steven Ley Lab
02/11/17 EvanCarder@WipfGroup 5
Angew. Chem., Int. Ed. 2003, 42, 5996.Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 12073.Chem. Eur. J. 2007, 13, 5688.Org. Lett. 2007, 8, 2879.
Me
H
O
(S)-(+)-Carvone
H
O
ClMe
THPOTBDPSO
H
CO2MeH
Favorskii ringcontraction
3-steps 3-steps
Evan Carder @ Wipf Group Page 5 of 24 8/7/2017
Ley Lab
02/11/17 EvanCarder@WipfGroup 6
TBDPSO
H
CO2MeH
TBDPSO
H
H
Me OMOM
OEtTESO
9-steps TBDPSO
H
H2-steps
OTESO
Me OMOM
OH
enol etherring closing methasis
Evan Carder @ Wipf Group Page 6 of 24 8/7/2017
Ley Lab
02/11/17 EvanCarder@WipfGroup 7
TBDPSO
H
H OTESO
Me OMOM
OH 2-steps TBDPSO
H
HTESO
Me OMOM
OO
Me
9-steps O
H
H
Me OH
O
OO
HO
OMe
Dihydroxylation; translactonization
Evan Carder @ Wipf Group Page 7 of 24 8/7/2017
Ley Lab
02/11/17 EvanCarder@WipfGroup 8
O
H
H
Me OH
O
OO
HO
OMe
14-steps OMe
HMe OAc
OPrOO
O
Me6
HO
OO
OHMe
Thapsigargin42-steps, 0.61% overall yield
O
MeMe
late-stage a-oxidation;regioselective acylations
Evan Carder @ Wipf Group Page 8 of 24 8/7/2017
Toward the Synthesis by the Guillermo Massanet Lab
02/11/17 EvanCarder@WipfGroup 9
O1. KOH, O2
MeOH, rt, 48 h
70%(+)-Dihydrocarvone
Me
MeOMe
+ Me
Me
OMe OH
2. DDQ, 1,4-dioxane
refluxing, 20 h
85%
Me
Me
OMe OH
RobinsonAnnulation
Org. Lett. 2006, 8, 2879.
Evan Carder @ Wipf Group Page 9 of 24 8/7/2017
Massanet Lab
02/11/17 EvanCarder@WipfGroup 10
3. Burgess reagent
PhH, rt-50 oC, 5 hMe
Me
OMe OH
Me
OMe
98%
4. AD-mix-a
tBuOH, H2O 0 oC, 15 h
Me
OMe OH
OHMe
76%
AD-mix-a
§ K2OsO4 2H2O§ K3Fe(CN)4§ K2CO3§ (DHQ)2PHAL
Burgess Reagent
O N-O
S N+O O
Sharpless assymetricdihydroxylation
Evan Carder @ Wipf Group Page 10 of 24 8/7/2017
Massanet Lab
02/11/17 EvanCarder@WipfGroup 11
Me
OMe OH
OHMe
5. hv
1:1 AcOH: H2O rt, 2.5 h
93%
O
Me
H
OH
OHMe
Me OAc
6. OsO4, NMO, CH3SO2NH2
tBuOH/H2O/acetone 0 oC-rt, 24 h
O
Me
H
OH
OHMe
Me OAc
HO
HO
61%
J. Chem. Soc. 1957, 929.
Me
OMe
hv
AcOH
30-38%
O
Me
HMe OAc
O O
HMe H
MeO O
Precedence:
Me
OMe
hv
AcOH
39%
O
Me
HMe OAc
O O
HMe H
MeO O
J. Chem. Soc. 2005, 127, 18.
Evan Carder @ Wipf Group Page 11 of 24 8/7/2017
Massanet Lab
02/11/17 EvanCarder@WipfGroup 12
7. TEMPO, NaClO, NaClO2
MeCN, pH 7 buffer rt, 4 h
98%7,11-Dihydoxyguaianolide
O
Me
H
OH
OHMe
Me OAc
HO
HO O
Me
HMe OAc
HO
OO
OHMe
Evan Carder @ Wipf Group Page 12 of 24 8/7/2017
Total Synthesis by the Phil Baran Lab
02/11/17 EvanCarder@WipfGroup 13
RobinsonAnnulation
O
1. KOH, MeOH 0 oC - rt, 15 h rt - 65 oC, 3.5 h
then O2, rt, 12 h
50%[gram-scale]
(+)-Dihydrocarvone
Me
MeOMe
+ Me
Me
OMe OH
2. TMSOTf, Et3N CH2Cl2, 0 oC, 2.5 h
then NBS, 0 oC, 3 h then DBU, 50 oC, 18 h then HCl, rt, 5 h
85%[gram-scale]
Me
Me
OMe OH
ACS Cent. Sci. 2017, 3, 47.
Evan Carder @ Wipf Group Page 13 of 24 8/7/2017
02/11/17 EvanCarder@WipfGroup 14
3. Burgess reagent DCE, 80 oC, 5.5 h then AD-mix-B tBuOH, H2O 0 oC, 24 h
[gram-scale]
Me
Me
OMe OH
Me
OMe OH
OHMe
60% dr. 5:1
4. TBSCl, Imidazole THF, rt, 24 h
then SeO2, NaHCO3 dioxane, 105 oC, 24 h
[gram-scale]
Me
OMe OTBS
OHMe
52% dr. 5:1
OH
Baran Lab
Sharpless assymetricdihydroxylation
Evan Carder @ Wipf Group Page 14 of 24 8/7/2017
02/11/17 EvanCarder@WipfGroup 15
5. PBu3, DEAD butyric acid
THF, 0 oC - rt, 16 h
[gram-scale]
Me
OMe OTBS
OHMe
OH Me
OMe OTBS
OHMe
O
PrO
60% dr. 5:1
6. AcOH, hv
rt, 23 h
[gram-scale] 50%
O
Me
H
OTBS
OHMe
Me OAc
OPrO
Baran Lab
MitsunobuReaction
Precedence:
Org. Lett. 2006, 8, 2879.
Me
OMe OH
OHMe
hv
1:1 AcOH: H2O rt, 2.5 h
93%
O
Me
H
OH
OHMe
Me OAc
Evan Carder @ Wipf Group Page 15 of 24 8/7/2017
02/11/17 EvanCarder@WipfGroup 16
7. KMnO4, octanoic acid octanoic anhydride
benzene, 85 oC, 20 h
[gram-scale] 50%
O
Me
H
OTBS
OHMe
Me OAc
OPrO
O
Me
H
OTBS
OHMe
Me OAc
OPrOO
O
Me6 8. OsO4, NMO, citric acid
tBuOH/H2O/acetone (1:1:1) 50 oC, 13 h
[gram-scale]33%, R = H23%, R = TBS
O
Me
H
OR
OHMe
Me OAc
OPrOO
O
Me6
HO
HO
Baran Lab
Upjohn dihydroxylation
Evan Carder @ Wipf Group Page 16 of 24 8/7/2017
02/11/17 EvanCarder@WipfGroup 17
9. Py SO3, pyridine DIPEA, DMSO CH2Cl2, 0 oC, 0.5 h
[gram-scale]
O
Me
H
OH
OHMe
Me OAc
OPrOO
O
Me6
HO
HO O
Me
HMe OAc
OPrOO
O
Me6
HO
OO
OHMe
43%
10. Zn(BH4)2, Et2O
-20 oC, 4 hHO
Me
HMe OAc
OPrOO
O
Me6
HO
OO
OHMe
88%
Baran Lab
Parikh-DoeringOxidation
Evan Carder @ Wipf Group Page 17 of 24 8/7/2017
02/11/17 EvanCarder@WipfGroup 18
Baran Lab
11. PhCOCl, Et3N angelic acid, toluene
90 oC, 72 hHO
Me
HMe OAc
OPrOO
O
Me6
HO
OO
OHMe
88%
OMe
HMe OAc
OPrOO
O
Me6
HO
OO
OHMe
59%Thapsigargin
11-steps, 0.137% overall yield
O
MeMe
Evan Carder @ Wipf Group Page 18 of 24 8/7/2017
02/11/17 EvanCarder@WipfGroup 19
Me
HH
O
1. tBuOCl, SiO2 pentane, rt, 12 h
2. Dibal-H, CH2Cl2 -78 oC, 0.5 h; then TBSCl, imidazole -78 oC - rt, 12 h
Me
ClH
OTBS
88% (two steps)dr > 19:1
Me
H
OTBS
E = CO2Me93%
dr > 8:1
OBnO
EOTMSMe
3. Pd2(dba)3 CHCl3 (S)-BINAP, LiCl THF, 0 oC, 0.5 h
then LiHMDS, 9 THF, 0 oC, 36 h
[gram-scale]
[gram-scale]
BnOO
CO2MeTMSO Me 9
(R)-(-)-Carvone
Current work: P. Andrew Evans LabJ. Am. Chem. Soc. 2017, 139, 6046.
BnOO
CO2MeTMSO Me 9
BnO CO2Me
Me
AD-mix-B, MeSO2NH2
tBuOH, H2O0 oC, 18 h
BnO CO2MeHO Me
OH(COCl)2, DMSOEt3N, CH2Cl2-78-0 oC, 1 h
then TMSCl, imidazole0 oC, 1 h
94% 75%
Synthesis of 9:
Evan Carder @ Wipf Group Page 19 of 24 8/7/2017
02/11/17 EvanCarder@WipfGroup 20
H
OBnO
EOTMSMe [gram-scale]
MeO
TBSOH
OBnMe
TBSOHO
O
O
OTMSMe
5. VCl3(THF)3, Zn HMPA, CH2Cl2, rt
added over 6 h
Guaianolide60%
dr > 19:1
Me
H
OTBS
E = CO2Me
OBnO
EOTMSMe
E = CO2Me40-55%
4. O3, EtOAc, -78 oC then Ph3P, -78 oC rt, 10 h
piperidinium acetate 78 oC, 12 h
[gram-scale]
Evans Lab
PinacolCoupling
Evan Carder @ Wipf Group Page 20 of 24 8/7/2017
02/11/17 EvanCarder@WipfGroup 21
H
OBnMe
TBSOHO
O
O
OTMSMe
Me OH
[gram-scale]
7. Ac2O, DMAP PhMe, 110 oC, 6 h
H
OBnMe
TBSOHO
O
O
OTMSMe
Me O
O
Me
85-96%
H
OBnMe
TBSOHO
O
O
OTMSMe
Guaianolide
[gram-scale]
6. Co(acac)2, PhSiH O2, EtOH, 0 oC, 2 h
79% dr > 19:1
Evans Lab
MukaiyamaHydration
Evan Carder @ Wipf Group Page 21 of 24 8/7/2017
02/11/17 EvanCarder@WipfGroup 22
9. (PrCO)2O, DMAP CH2Cl2, rt, 1h
then CrO3, acetone 0 oC, 5 h
H
OMe
HO
O
O
OHMe
Me O
O
Me
OPr
O
87%
H
OBnMe
TBSOHO
O
O
OTMSMe
Me O
O
Me
[gram-scale]
8. Pd(OH)2/C, H2 EtOAc, rt, 20 min; IBX, DMSO, rt, 12 h
then NaBH4 DMSO/MeOH (1:3) -10 oC, 5 min
94%dr > 19:1
H
OHMe
TBSOHO
O
O
OHMe
Me O
O
Me
Evans Lab
Evan Carder @ Wipf Group Page 22 of 24 8/7/2017
02/11/17 EvanCarder@WipfGroup 23
Evans Lab
61%
11. Zn(BH4)2, Et2O -20 oC, 10 h
12. NaHCO3, 17 PhMe, 90 oC, 45 h
H
OMe
HO
O
O
OHMe
Me O
O
Me
OPr
OO
OMe
6OMe
Me
64%Thapsigargin
12 steps, 5.8% overall yield
O
O
O
ArMe
Me
17Ar = 2,4,6-Cl3C6H2
H
OMe
HO
O
O
OHMe
Me O
O
Me
OPr
O 10. Mn(OAc)3 2H2O C7H15CO2H
benzene, reflux, 4 h
H
OMe
HO
O
O
OHMe
Me O
O
Me
OPr
OO
OMe
6
Evan Carder @ Wipf Group Page 23 of 24 8/7/2017
Summary
02/11/17 EvanCarder@WipfGroup 24
Total Synthesis: Creighton Lab Baran Lab Evans Lab
Key step(s)Favorskii
Rearrangement, Ring-closing metathesis
Photochemical ring contraction
Asymmetric allyl alkylation, Pinacol
coupling Linear Steps 42 11 12
Overall yield 0.61% 0.14% 5.8%42x
H
OMe
HO
O
O
OHMe
Me O
O
Me
OPr
OO
OMe
6OMe
Me
Thapsigargin
Me
HH
O
(R)-(-)-Carvone
Evan Carder @ Wipf Group Page 24 of 24 8/7/2017